• 1
    Kahl KG, Greggersen W, Schweiger U et al. Prevalence of the metabolic syndrome in unipolar major depression. Eur. Arch. Psychiatry Clin. Neurosci. 2012; 264: 313320.
  • 2
    Viinamaki H, Heiskanen T, Lehto SM et al. Association of depressive symptoms and metabolic syndrome in men. Acta Psychiatr. Scand. 2009; 120: 229.
  • 3
    Akbaraly TN, Kivimäki M, Brunner EJ et al. Association between metabolic syndrome and depressive symptoms in middle-aged adults: Results from the Whitehall II study. Diabetes Care 2008; 32: 499504.
  • 4
    Skilton M, Moulin P, Terra JL, Bonnet F. Associations between anxiety, depression, and the metabolic syndrome. Biol. Psychiatry 2007; 62: 12511257.
  • 5
    Almeida OP, Calver J, Jamrozik K, Hankey GJ, Flicker L. Obesity and metabolic syndrome increase the risk of incident depression in older men: The health in men study. Am. J. Geriatr. Psychiatry 2009; 17: 889898.
  • 6
    Mast BT, Miles T, Penninx BW et al. Vascular disease and future risk of depressive symptomatology in older adults: Findings from the Health, Aging, and Body Composition study. Biol. Psychiatry 2008; 64: 320326.
  • 7
    Takeuchi T, Nakao M, Nomura K et al. Association of the metabolic syndrome with depression and anxiety in Japanese men: A 1-year cohort study. Diabetes Metab. Res. Rev. 2009; 25: 762767.
  • 8
    Foley DL, Morley KI, Madden PA, Heath AC, Whitfield JB, Martin NG. Major depression and the metabolic syndrome. Twin Res. Hum. Genet. 2010; 13: 347358.
  • 9
    Hildmm B, Mykletun A, Midthjell K, Ismail K, Dahl AA. No association of depression and anxiety with the metabolic syndrome: The Norwegian HUNT study. Acta Psychiatr. Scand. 2009; 120: 1422.
  • 10
    Carroll D, Phillips AC, Thomas GN, Gale CR, Deary I, Batty GD. Generalized anxiety disorder is associated with metabolic syndrome in the Vietnam experience study. Biol. Psychiatry 2009; 66: 9193.
  • 11
    Pan A, Keum N, Okereke OI et al. Bidirectional association between depression and metabolic syndrome: A systematic review and meta-analysis of epidemiological studies. Diabetes Care 2012; 35: 11711180.
  • 12
    Ministry of Health, Labour and Welfare. Information of medical check-ups for metabolic syndrome. Ministry of Health, Labour and Welfare. [Cited 28 Feb 2012.] Available from URL: (in Japanese).
  • 13
    Health and Welfare Statistics Association (ed.). Patient Survey, Vol. I. Health and Welfare Statistics Association Press, Tokyo, 2005 (in Japanese).
  • 14
    Nakao M, Takeuchi T. The suicide epidemic in Japan and strategies of depression screening for its prevention. Bull. World Health Organ. 2006; 84: 492493.
  • 15
    Parker G, Roy K, Mitchell P, Wilhelm K, Malhi G, Hadzi-Pavlovic D. Atypical depression: A reappraisal. Am. J. Psychiatry 2002; 159: 14701479.
  • 16
    American Psychiatric Association. DSM-IV-TR. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC, 2000.
  • 17
    Lamers F, de Jonge P, Nolen WA et al. Identifying depressive subtypes in a large cohort study: Results from the Netherlands Study of Depression and Anxiety (NESDA). J. Clin. Psychiatry 2010; 71: 15821589.
  • 18
    McIntyre RS, Soczynska JK, Konarski JZ et al. Should depressive syndromes be reclassified as ‘metabolic syndrome type II'? Ann. Clin. Psychiatry 2007; 19: 257264.
  • 19
    International Diabetes Foundation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. IDF Communications, Brussels, 2006.
  • 20
    Takeuchi T, Nakao M, Yano E. Symptomatology of depressive state in the workplace. A 20-year cohort study. Soc. Psychiatry Psychiatr. Epidemiol. 2008; 43: 343348.
  • 21
    Nakao M, Yano E. Reporting of somatic symptoms as a screening marker for detecting major depression in a population of Japanese white-collar workers. J. Clin. Epidemiol. 2003; 56: 10211026.
  • 22
    Kawakami N, Takeshima T, Ono Y et al. Twelve-month prevalence, severity, and treatment of common mental disorders in communities in Japan: Preliminary finding from the World Mental Health Japan Survey 2002–2003. Psychiatry Clin. Neurosci. 2005; 59: 441452.
  • 23
    West ED, Dally PJ. Effects of iproniazid in depressive syndromes. Br. Med. J. 1959; 1: 14911494.
  • 24
    Liebowitz MR, Klein DF. Hysteroid dysphoria. Psychiatr. Clin. North Am. 1979; 2: 555575.
  • 25
    Vaidya V. Psychosocial aspects of obesity. Adv. Psychosom. Med. 2006; 27: 7385.
  • 26
    Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, Lawlor DA. Exercise for depression. Cochrane Database Syst. Rev. 2008; (4): CD004366.
  • 27
    Vogelzangs N, Suthers K, Ferrucci L et al. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology 2007; 32: 151159.
  • 28
    Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: A meta-analysis. Diabetes Care 2008; 31: 23832390.
  • 29
    Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosom. Med. 2009; 71: 171186.
  • 30
    Pan A, Ye X, Franco OH et al. Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: Findings from the Nutrition and Health of Aging Population in China Study. J. Affect. Disord. 2008; 109: 7582.
  • 31
    Stewart JW, McGrath PJ, Rabkin JG, Quitkin FM. Atypical depression. A valid clinical entity? Psychiatr. Clin. North Am. 1993; 16: 479495.
  • 32
    The World Health Organization. World Health Report 2001, Mental Health: New Understanding, New Hope. WHO, Geneva, 2001.
  • 33
    The World Health Organization. The Global Burden of Disease: 2004 Update. WHO Library Cataloguing-in-Publication Data. WHO, Geneva, 2008.